iRhythm Technologies

1 open role

iRhythm Technologies makes the Zio wearable ECG patch and the cardiac monitoring service built around it: a patient wears the device for up to two weeks, and the recorded heartbeat data runs through an FDA-cleared deep-learning algorithm and a review by qualified cardiac technicians before a report reaches the physician. The buyers are cardiology and electrophysiology practices and primary care clinics, paid through healthcare reimbursement, and the company reports over 12 million patients analyzed and two billion hours of curated heartbeat data. The product surface is unusually wide for a medtech company, spanning the ZioSuite clinician portal, the MyZio patient app, EHR integrations, and the reports themselves. iRhythm is publicly traded on Nasdaq.